The net-revenue sales for Grünenthal’s Thalidomide containing products kept on rising. In November 1960 it reached 1,215,600 Deutschmarks.

Source: Anklageschrift (indictment) from 1967, today archived at the National Archives of North Rhine-Westphalia in Duisburg, Germany (Rheinland Division, Gerichte Rep. 139, No. 1–396), p. 97.